|Bid||86.20 x 800|
|Ask||86.49 x 800|
|Day's Range||86.15 - 86.59|
|52 Week Range||60.16 - 90.00|
|Beta (3Y Monthly)||1.18|
|PE Ratio (TTM)||23.40|
|Forward Dividend & Yield||1.60 (1.87%)|
|1y Target Est||N/A|
FMC Corp. CEO Pierre Brondeau cashed out more than 151,000 company shares last week in a transaction that netted him about $10.5 million. The options allowed Brondeau to purchase 84,947 shares at $41.20, the stock price when the options were awarded, and 66,519 shares for $51.48 per share, according to a filing with the U.S. Securities and Exchange Commission. In a statement, an FMC (NYSE: FMC) spokesperson said Brondeau "retains a very significant personal stake in FMC stock" and added the sales were for personal financial management.
CEO and Chariman of Bd of Fmc Corp (30-Year Financial, Insider Trades) Pierre R Brondeau (insider trades) sold 196,466 shares of FMC on 08/09/2019 at an average price of $88.9 a share. Continue reading...
FMC (FMC) delivered earnings and revenue surprises of 1.84% and 0.47%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
The tide is turning for these four stocks, according to the Street’s latest activity. These four stocks have received multiple analyst upgrades recently. Given that analysts usually reiterate recommendations, upgrades are a clear sign of increasing confidence in a company’s outlook. And when more than one analyst makes such a bold move, it’s time to pay attention. With this in mind, let’s take a closer look at four stocks showing particularly bullish signals from the Street right now: Lyft Inc (LYFT)- the light is changing from yellow to greenAnalysts are beginning to change their tune on ride-sharing stock Lyft. Despite the company’s 'awkward' IPO, bitter rivalry with market-leader Uber Technologies Inc (UBER), and current loss-making status- there is still much to celebrate about Lyft says the Street. “We are upgrading LYFT shares to Outperform from Neutral after Lyft exhibited in 2Q19 many of the indicators we had been looking for to get more positive on the story” cheered Wedbush analyst Daniel Ives (a 5-star analyst according to TipRanks) on August 7. He made the call after Lyft reported better than expected active riders, revenue per active rider, ridership, and profitability in its latest earnings report. This “was a major step in the right direction in our opinion towards gaining much needed Street credibility” commented Ives post-report.“Where we once viewed the domestic only nature of Lyft as a detractor, we are beginning to view it as more of a near-term benefit given the execution we are seeing from Lyft in the field around key metrics, as the competitive dynamics domestically are much stronger than they are internationally” the analyst told investors.In particular, Ives noted better operating leverage and a clearer path to profitability. “2018 turns into the peak loss year as Lyft sees y/y improvement in EBITDA losses, a year earlier than expected” he noted. As a result this top analyst bumped up his Lyft price target to $75 from $67 on higher estimates/ multiples. Indeed, on the earnings call, Lyft CFO Brian Roberts suggested that higher prices "will accelerate Lyft’s path to profitability, and further, we believe these price adjustments reflect an industry trend.” Overall Lyft shows a Moderate Buy analyst consensus. That’s with another recent upgrade from Atlantic Equities analyst James Cordwell (a 4-star analyst). He boosted Lyft to Hold from Sell, while raising his price target $8 to $60 post-earnings. FMC Corp (FMC)- putting patent expiry fears to rest If you haven’t heard of this niche stock before, welcome to an intriguing investing opportunity. FMC offers specialty Crop Protection Chemical exposure (~90% of sales, primarily herbicides and insecticides). Although the company currently licenses technology from larger developers, it is now hoping to develop its own Active Ingredients (AI’s) after snapping up DD Crop Protection’s assets.“Given that FMC has key process and formulation patents that protect Rnaxypyr and Cyazypyr through 2025+, along with its well-built infrastructure and option on selling AIs to competitive third parties, our initial fears of competitive generic products are well put to rest” celebrated top RBC Capital analyst Arun Viswanathan (a 5-star analyst) on August 9. “We upgrade FMC to Outperform from Sector Perform, as we had mistakenly thought the patent “cliff” in 2022 would result in a quicker deterioration of sales and EBITDA based on prior patent expiration in health care” the analyst told investors. Instead, FMC noted 16 key process patents that extend the protection date well past 2022. And from 2025, data protection in Europe and government registration timeline in US should extend the timeline even further says Viswanathan. At the same time, as FMC pointed out on its recent earnings call, manufacturing complexity is a high barrier to entry. FMC benefits from cost, scale advantages, and superior execution experience. The analyst also praised FMC for slashing Brazil exposure (already high channel inventories) and focusing on soybeans to benefit from an estimated ~400% soybean demand growth over next the decade. Meanwhile Goldman Sachs analyst Adam Samuelson (a 1-star analyst) upgraded FMC Corporation to Buy while bumping up his price target to $100 from $88. He termed FMC a "unique crop protection pure-play" with robust growth prospects and a "healthy" pipeline of crop protection active ingredients. Samuelson is now predicting that the company will record more than twice the annual revenue growth through 2023 vs other crop chemical stocks. FMC holds a 'Strong Buy' Street consensus. Stitch Fix Inc (SFIX)- the fix is inOnline personal styling pioneer Stitch Fix has received two back-to-back upgrades recently. Both Goldman Sachs and Stifel Nicolaus gave the stock the thumbs up- with prices looking more attractive now SFIX is trading down 20% on a one-month basis.Investors are feeling jittery about the stock after 1) a slowdown in active client growth and 2) threats from Amazon (AMZN). The e-commerce king has just announced that it is expanding deeper into the world of fashion via its new Personal Shopper by Prime Wardrobe service. Although shipping and returns are free, Prime members pay $4.99 to receive the specially selected items. Luckily for SFIX, Wells Fargo notes that the reaction from customers to Prime Wardrobe has so far met only ‘muted success.’ “While this gained some traction, a large number of consumers viewed the experience as overwhelming due to the number of products to choose from (a common issue we believe has held back Amazon’s ability to drive meaningful share in “fashion” apparel)” comments the firm.What’s more, top Stifel Nicolaus analyst Scott Devitt (a 5-star analyst) isn’t concerned about the slowing client growth. He writes “Despite the slowdown in active client growth, we are confident in management’s ability to drive healthy ARPU growth in the intermediate term by continuing to improve keep rates through stronger personalization (Style Shuffle), high-quality client adds, and healthy retention.” Devitt believes that the scaling of the U.K. business represents an additional opportunity for active client growth, as do new features/capabilities. “The ability to buy individual items and the potential to add more items per fix, could support further upside” the analyst tells investors. Rental provides another option to boost growth. On the F3Q:19 earnings call, CEO Katrina Lake said the company was looking at the rental market. At the same time he believes exclusive offers, the scaling of men’s business and shipping efficiencies should continue to benefit growth margins. With a forecast revenue growth of 19% CAGR over the next three years, Devitt has a $35 price target on the stock- marginally below Goldman Sachs' $38 price target. “Although we are forecasting a ~19% revenue CAGR through FY:22, we believe the favorable ARPU trends and the potential for new features/services are increasing the likelihood that Stitch Fix outperforms our revenue growth expectations” the analyst writes. Overall the stock scores a Moderate Buy Street consensus, based on the last three months of analyst ratings. Snap Inc (SNAP)- a newly augmented reality Last but not least comes disappearing photo app creator Snap Inc. The stock has put on a jaw-dropping rally in 2019- exploding over 200% since the beginning of the year. That was helped by the company reporting a solid beat and raise quarter back at the end of July. “Revenue growth accelerated, DAU growth turned sharply positive, Gross Margin expanded nicely & EBITDA loss narrowed materially – a 4- part Summer Cocktail” exclaimed five-star RBC Capital analyst Mark Mahaney (a 5-star analyst) post-earnings. So it is not surprising the stock has also scored several upgrades from the Street. We are talking about upgrades from UBS, Aegis Capital and Summit Redstone Partners- and before that, Goldman Sachs. “Snap's 2Q19 results confirmed our work that led to our intra-quarter upgrade of the stock to Buy from Hold” commented Aegis Capital’s Victor Anthony (a 5-star analyst). Following the results this Top 100 analyst boosted his price target from $17 to $19 (12% upside potential), writing “we continue to be firm buyers of the stock.” Snap's fundamentals have clearly improved, Anthony said, and the improvement is sustainable. This is something the analyst picked up on at the time of the stock’s upgrade where he highlighted Snap’s increasing per-user engagement, increasing advertiser interest, and revenue expansion opportunities. “We walk back our previous assertion that Evan Spiegel should find a buyer for the business - Snap can stand on its own.” Anthony told investors in June. “This is our first Buy rating on the stock since our pre-IPO initiation work, when we were skeptical of Snap's ability to drive user growth, concerned that the ad platform was inferior to competitors in terms of targeting and analytics, and concerned that there was no clear path towards profitability and positive cash flow inflection.”And the analyst makes a valuable point when he adds that “Snap is largely absent from the privacy, antitrust, and regulatory discourse in the U.S. that is increasing the risks to owning FAANG stocks.” Based on 26 recent ratings, analysts have a Moderate Buy consensus on SNAP right now.Visit TipRanks’ Analysts’ Top Stocks tool, to find out which companies Wall Street’s top analysts are bullish on right now.
Among the Philadelphia region’s largest 20 publicly traded companies, three in the chemical industry experienced the biggest dips in midday trading.
FMC (FMC) delivered earnings and revenue surprises of 1.84% and 0.47%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Corp NYSE:FMCView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is low for FMC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding FMC are favorable, with net inflows of $7.84 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Basic Materialsis falling. The rate of decline is significant relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. FMC credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Philadelphia-based FMC will be making a $50 million investment to enhance a 515-acre campus near Newark, Del., that it acquired from DuPont in 2017. FMC (NYSE: FMC) plans to upgrade an existing building on the Stine Research Center to enhance its R&D efforts. The campus was part of the 2017 acquisition of portions of DuPont's crop protection business by FMC.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
A sizeable chunk of Tuesday's intraday gain was given back before the closing bell rang, though even then the S&P 500 was able to muster a 0.97% win. But, between the bullish gap and the headlines needed to make it happen, it's anyone's guess as to where things go from here.Source: Allan Ajifo via Wikimedia (Modified)Snap (NYSE:SNAP), parent company of Snapchat, was arguably the most noteworthy winner, rallying nearly 10% after BTIG upped its price target to $20. General Electric (NYSE:GE) did more to help the overall market though, gaining almost 4% after long-term doubter John Inch, analyst with Gordon Haskett, conceded that at the very least, GE wouldn't face insolvency. Fanning those bullish flames is a projection that General Electric expects this year's Paris Air Show to yield at least $35 billion worth of orders.Holding the market back more than any other name was La-Z-Boy (NYSE:LZB), down 1.5% during the regular hours session, but off more than 8% in after-hours action after posting poor fourth-quarter numbers after the closing bell rang.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer Except for GE, none make for great trading prospects headed into Wednesday's trading. And for that matter, stock charts of McCormick & Company (NYSE:MKC), FMC (NYSE:FMC) and Pfizer (NYSE:PFE) all look like better prospects than GE from a risk/reward perspective. Here's why. Pfizer (PFE)A little less than three weeks ago, Pfizer was featured as a name that was about to break out, but would have to clear an incredibly tough hurdle to do so. It did so. Namely, it not only broke above the upper boundary of a falling trading range, but broke above the pivotal 200-day moving average line, plotted in white on both stock charts.It's what has happened in the meantime that merits this second look. Although progress has been slow, thanks to yesterday's renewed strength, PFE is entirely back above the 200-day line and now knocking on the door of another resistance level. A move above that ceiling could prove catalytic, as there are no major technical ceilings left standing in the way. Click to Enlarge * The last line in question is $43.34, marked with a white dashed line on the daily chart. That's where Pfizer peaked in April, and where it peaked earlier this month. Shares are one good day away from moving above it. * Beyond that, plotted in red, the highs around $43.80 are the next most likely stumbling blocks, though it's likely they're not a terribly big factor at this point. * Bolstering the bullish case is how much volume took shape behind yesterday's modest advance. It's a subtle hint there are more bulls waiting in the wings, if they can just find enough to be confident about. McCormick & Company (MKC)McCormick & Company shares were nothing but bullish between January's deep low and the rally through early April … a move that reclaimed a miserable last few weeks of last year and rekindled the bullishness from the bulk of 2018.The past several weeks have been decidedly less bullish though. While still making forward progress, that progress was shallow and only driven by a modestly rising support line. And as of Tuesday, that line is on its last legs, and the sellers are starting to turn into a horde. * 10 Tech Stocks to Buy Now for 2025 Click to Enlarge * The support line in question is marked as a white dashed line on both stock charts, tagging all the key lows going back to early April. You have to look closely to see it, but Tuesday's weakness actually broke under that line. * Simultaneously, yesterday's 1.18% setback dragged MKC under the purple 50-day moving average line, which had served as a support line earlier in the month. * Zooming out to the weekly chart of McCormick & Company we can see weakness has already developed in earnest, even if the trend is still "up." The Chaikin line is en route to fall below zero, and we're just one more bad week away from a bearish MACD crossunder. FMC (FMC)Since the middle of last year, FMC has made several attempts to break above what's become a well-established resistance line right around $80.75. Clearly each attempt has failed, resulting on various levels of selloffs.The buyers are at it again though, and this time the outcome may well be different. This time, the effort is starting out from a point that wasn't so deep in the hole. With less ground to cover just to get into position for a breakout thrust, there's more gas in the tank to actually get the stock over the hump. Click to Enlarge * That "hump" is plotted with a yellow dashed line on both stock charts. Although not perfect resistance, it's clear there's something about that level holding FMC shares back. If it can be hurdled, the buying floodgates could readily open. * Last month's low around $71 is a much healthier start to the effort than the December low near $61 was. * Backing out to see the weekly chart we can readily identify a bullish undertow in the Chaikin line as well as with the fresh MACD crossover.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Value Stocks to Buy for the Second Half * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer * 6 Chip Stocks Staring At Big Headwinds in 2019 Compare Brokers The post 3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company appeared first on InvestorPlace.
Forecast-topping earnings performance in the first quarter and upbeat outlook have contributed to the gains in FMC Corp's (FMC) shares.
Back in 2002 Stephen J. Errico, a Wall Street investor, who now has more than 30 years of professional investing experience, launched his own NYC-based hedge fund, Locust Wood Capital Advisers. Aside from being the fund's founder he is also its CIO and Controling Principal. Previously, Mr. Errico worked at Morgan Stanley as a portfolio […]
See how much companies like Comcast and Five Below pay their employees and CEOs. One Philadelphia-area CEO makes more than 900 times what the median employee does at his company.